- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-08-01-2019
Pharmaceutical Technology
Pharma Contract Market Update
August 02, 2019
Features
2019 Supplement
4
CMOs and CDMOs expanded their services and facilities in the summer of 2019.
Gene-Editing Techniques Target New Applications
August 01, 2019
Features
2019 Supplement
4
Industry experts discuss the role of gene-editing techniques in regenerative medicine and cell-line development.
Designing Phase-Appropriate CMC Analytical Programs
August 01, 2019
Features
2019 Supplement
4
A one-size-fits-all strategy is not the best approach for the development of a chemistry, manufacturing, and controls program.
De-risking Biologics Development Through Advanced Mass Spectrometry Approaches
August 01, 2019
Features
2019 Supplement
4
Using advanced HDX-MS and native MS techniques can improve the identification of potentially successful biologic drugs and de-risk CMC and clinical designs.
Industrializing Cell and Gene Therapies
August 01, 2019
Features
2019 Supplement
4
Now that the first genetically modified cell therapies are being manufactured, the industry must move beyond “whatever works” to meet growing demand.
Ensuring Manufacturing of HPAPIs Under Safe Conditions
August 01, 2019
Features
2019 Supplement
4
Pharmaceutical Technology spoke with Anil Kane, executive director, global science and technology, pharmaceutical development services, at Thermo Fisher Scientific about the industry’s need for more capacity in the manufacture of highly potent APIs.
HPAPI Capacity Challenges
August 01, 2019
Features
2019 Supplement
4
Does the pharmaceutical industry have adequate access to contained equipment, facilities, and infrastructure for the manufacture of highly potent APIs?
Best Practices for Selecting a Service Provider
August 01, 2019
Features
2019 Supplement
4
Key considerations when searching for an analytical service provider include workflow, hardware, and regulatory support.
From Data to Information
August 01, 2019
Features
2019 Supplement
4
Making siloed data accessible across functions and to contract partners is the first step to facilitating continuous improvement and enabling use of artificial intelligence in manufacturing.
GLPs: Better Data Access Needed to Improve Compliance
August 01, 2019
Features
2019 Supplement
4
Tools help lab scientists capture and use more data and work to ensure data integrity.
Use of AI is Growing in Pharma
August 01, 2019
Features
2019 Supplement
4
Bio/pharmaceutical companies are adopting artificial intelligence for discovery, development, risk assessment, safety monitoring, and manufacturing.
Why Dread Your Next FDA Inspection?
August 01, 2019
Features
2019 Supplement
4
Performing a compliance gap assessment and focusing on six key factors in your facility’s process definition and controls can help your facility pass its next FDA inspection with flying colors.
Pharmaceutical Technology North America, Outsourcing Resources 2019 Supplement (PDF)
August 01, 2019
Issue PDF
2019 Supplement
4
Click the title above to open the Pharmaceutical Technology Outsourcing Resources 2019 in an interactive PDF format.